Top Sell
| Wertpapier | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc. | 0 | 5 | 0 | 1 | 2,30 € | - | - |
| Savara Inc. | 1 | 1 | 0 | 1 | 4,62 € | 8,00 € | 73,16 % |
| Revance Therapeutics Inc. | 0 | 2 | 0 | 1 | 2,78 € | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | 7,45 € | 58,50 € | 685,23 % |
| Gritstone Oncology Inc | 3 | 2 | 0 | 0 | 0,76 € | 6,43 € | 741,01 % |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | 0,64 € | 3,00 € | 370,81 % |
| Fibrogen Inc. | 1 | 2 | 0 | 0 | 1,10 € | 6,00 € | 444,96 % |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 0 | 0 | 0,22 € | 14,66 € | 6565,59 % |
| Inotiv Inc. | 3 | 1 | 1 | 0 | 1,97 € | 10,66 € | 441,20 % |
| Organovo Holdings Inc. | 0 | 7 | 0 | 0 | 0,96 € | 3,00 € | 213,15 % |
| Omeros Corp. | 2 | 4 | 0 | 0 | 3,06 € | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | 1,90 € | 3,00 € | 57,81 % |
| Trevena Inc. | 2 | 14 | 1 | 0 | 0,34 € | 6,48 € | 1784,30 % |
| Sage Therapeutics Inc. | 5 | 3 | 0 | 0 | 11,04 € | 26,71 € | 141,98 % |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | 0,92 € | 6,49 € | 606,48 % |
| Ionis Pharmaceuticals Inc. | 19 | 5 | 0 | 0 | 34,40 € | 56,86 € | 65,30 % |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | 1,55 € | 18,37 € | 1084,90 % |
| Fate Therapeutics Inc. | 4 | 3 | 0 | 0 | 3,40 € | 8,27 € | 143,48 % |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | 0,35 € | - | - |
| Arca Biopharma | 0 | 21 | 0 | 0 | 3,00 € | - | - |
| Acadia Pharmaceuticals | 28 | 1 | 0 | 0 | 13,74 € | 31,78 € | 131,33 % |
| Bristol-Myers Squibb | 11 | 3 | 0 | 0 | 38,95 € | 67,64 € | 73,66 % |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | 0,34 € | 21,06 € | 6072,33 % |
| Cytomx Therapeutics Inc | 1 | 1 | 0 | 0 | 1,72 € | 50,00 € | 2810,36 % |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | 4,09 € | - | - |